HUINNO AIM aids medical decisions by creating diagnostic and predictive systems through AI analysis of biometric signals and patient data




AI-based CDSS supports treatment planning and priority
determination through real-time analysis of patient biometric signals
GW
ICU
ER
Leading medical innovation with AI-based Vital-PICASO, IoMT and BP estimation

MFDS Approved
Vital-PICASO
(MEMO CAST)
A solution that supports clinical decision-making — a screening tool that predicts patient deterioration in advance and prioritizes which patients to review

Work In Progress
IoMT
(Internet of Medical Things)
We monitor and share health data in real time, making it easy for patients and healthcare professionals to check and manage health information
R&D in Progress
BP Estimation
(Cuffless Blood Pressure)
A medical device that estimates blood pressure from PPG and ECG signals, for use in operating rooms, intensive care units and general wards




Securing large-scale data, AI technology, our team members and
advisory medical staff are the strengths of HUINNO AIM

Labeled
Big Data

AI
Technology

Experienced
Team

AI
Technology
Our specialized medical AI team members and
top advisory medical staff lead HUINNO AIM
Seong Si Baek(CEO)
Chief Executive Officer

Gil Yeong Joon(CSO)
Chief Scientific Officer

Ryu Ho Geol(CMO)
Chief Medical Officer

Yoon Sung Roh
Advisor

Kim Hee Chan
Advisor

Son Ho Sung
Advisor

Oh Il Young
Advisor


Welfare benefits expand along with the company's growth
Annual welfare points
Flexible hours &
Support for the latest equipment
Referral bonus
Paid leave provided for long-term employees